Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Dec 21:8:1887.
doi: 10.3389/fimmu.2017.01887. eCollection 2017.

Accomplices of the Hypoxic Tumor Microenvironment Compromising Antitumor Immunity: Adenosine, Lactate, Acidosis, Vascular Endothelial Growth Factor, Potassium Ions, and Phosphatidylserine

Affiliations
Review

Accomplices of the Hypoxic Tumor Microenvironment Compromising Antitumor Immunity: Adenosine, Lactate, Acidosis, Vascular Endothelial Growth Factor, Potassium Ions, and Phosphatidylserine

Peter Vaupel et al. Front Immunol. .

Abstract

In this minireview, we aim to highlight key factors of the tumor microenvironment, including adenosine, lactate, acidosis, vascular endothelial growth factor, phosphatidylserine, high extracellular K+ levels, and tumor hypoxia with respect to antitumor immune functions. Most solid tumors have an immature chaotic microvasculature that results in tumor hypoxia. Hypoxia is a key determinant of tumor aggressiveness and therapy resistance and hypoxia-related gene products can thwart antitumor immune responses.

Keywords: acidosis; adenosine; antitumor immunity; lactate; phosphatidylserine; potassium ions; tumor hypoxia; vascular endothelial growth factor.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Adenosine (ADO) concentration measured in experimental tumors (DS-sarcomas, n = 26) as a function of the tissue oxygenation status. With decreasing mean tumor pO2 values, ADO accumulates in the tumor reaching ~100 µM in severely hypoxic tumors. For comparison, ADO levels in normal tissues are in the range of 10–100 nM (16, 17).
Figure 2
Figure 2
Flow chart describing “classical” hypoxia-/HIF-1α-driven features of the tumor microenvironment (TME) responsible for the local inhibition of antitumor immunity, for tumor progression/recurrence and poor patient outcome (see also list of abbreviations).

References

    1. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell (2011) 144:646–74.10.1016/j.cell.2011.02.013 - DOI - PubMed
    1. Rivera LB, Bergers G. CANCER. Tumor angiogenesis, from foe to friend. Science (2015) 349:694–5.10.1126/science.aad0862 - DOI - PubMed
    1. Potente M, Gerhardt H, Carmeliet P. Basic and therapeutic aspects of angiogenesis. Cell (2011) 146:873–87.10.1016/j.cell.2011.08.039 - DOI - PubMed
    1. Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res (1989) 49:6449–65. - PubMed
    1. Vaupel P. Tumor microenvironmental physiology and its implications for radiation oncology. Semin Radiat Oncol (2004) 14:198–206.10.1016/j.semradonc.2004.04.008 - DOI - PubMed